Although the clinical significance of KL-6 is emerging in the CTD-ILD field, its role in the diagnosis and measurement of ILD requires clarification in patients with various autoimmune diseases that are potentially accompanied by ILD. Here, MUC1 is linked to interstitial lung disease.